102 related articles for article (PubMed ID: 19919810)
21. Host defenses against human papillomaviruses: lessons from epidermodysplasia verruciformis.
Orth G
Curr Top Microbiol Immunol; 2008; 321():59-83. PubMed ID: 18727487
[TBL] [Abstract][Full Text] [Related]
22. Myelodysplastic syndromes: the pediatric point of view.
Locatelli F; Zecca M; Pession A; Maserati E; De Stefano P; Severi F
Haematologica; 1995; 80(3):268-79. PubMed ID: 7672722
[TBL] [Abstract][Full Text] [Related]
23. Epidermodysplasia verruciformis associated with plasmablastic lymphoma and hepatitis B virus infection.
Shayanfar N; Babaheidarian P; Rahmani H; Azadmanesh K; Sohrabi A; Mohammadpour M; Mirzaie AZ; Parvaneh N
Acta Dermatovenerol Croat; 2012; 20(4):267-71. PubMed ID: 23317490
[TBL] [Abstract][Full Text] [Related]
24. Subungual Bowen disease in a patient with epidermodysplasia verruciformis presenting clinically as longitudinal melanonychia.
Stetsenko GY; McFarlane RJ; Chien AJ; Fleckman P; Swanson P; George E; Argenyi ZB
Am J Dermatopathol; 2008 Dec; 30(6):582-5. PubMed ID: 19033934
[TBL] [Abstract][Full Text] [Related]
25. Development of aggressive squamous cell carcinoma in epidermodysplasia verruciformis associated with human papillomavirus type 22b.
Kim T; Park JC; Roh MR; Park JM; Kim SH; Cho NH; Lee MG
Dermatology; 2010; 220(4):326-8. PubMed ID: 20460877
[TBL] [Abstract][Full Text] [Related]
26. Acquired epidermodysplasia verruciformis.
Rogers HD; Macgregor JL; Nord KM; Tyring S; Rady P; Engler DE; Grossman ME
J Am Acad Dermatol; 2009 Feb; 60(2):315-20. PubMed ID: 19150275
[TBL] [Abstract][Full Text] [Related]
27. [Intense neutropenia of 14 years duration as the only manifestation of a myelodysplastic syndrome].
Las Heras G; Marti JM; Villamor N; Ribera JM; Feliu E; Rozman C
Med Clin (Barc); 1995 Nov; 105(16):619-21. PubMed ID: 8523943
[TBL] [Abstract][Full Text] [Related]
28. Seborrheic Keratosis-like lesions in patients with epidermodysplasia verruciformis.
Roncalli de Oliveira W; Neto CF; Rady PL; Tyring SK
J Dermatol; 2003 Jan; 30(1):48-53. PubMed ID: 12598709
[TBL] [Abstract][Full Text] [Related]
29. Detection of Merkel cell polyomavirus in epidermodysplasia-verruciformis-associated skin neoplasms.
Mertz KD; Schmid M; Burger B; Itin P; Palmedo G; Schärer L; Kutzner H; Fernández Figueras MT; Cribier B; Pfaltz M; Kempf W
Dermatology; 2011 Feb; 222(1):87-92. PubMed ID: 21099200
[TBL] [Abstract][Full Text] [Related]
30. High prevalence of a variety of epidermodysplasia verruciformis-associated human papillomaviruses in psoriatic skin of patients treated or not treated with PUVA.
Weissenborn SJ; Höpfl R; Weber F; Smola H; Pfister HJ; Fuchs PG
J Invest Dermatol; 1999 Jul; 113(1):122-6. PubMed ID: 10417630
[TBL] [Abstract][Full Text] [Related]
31. [Genetics and susceptibility to human papillomaviruses: epidermodysplasia verruciformis, a disease model].
Orth G
Bull Acad Natl Med; 2010 Jun; 194(6):923-40; discussion 941. PubMed ID: 21513129
[TBL] [Abstract][Full Text] [Related]
32. Progression of myelodysplasia to acute lymphoblastic leukaemia: implications for disease biology.
Disperati P; Ichim CV; Tkachuk D; Chun K; Schuh AC; Wells RA
Leuk Res; 2006 Feb; 30(2):233-9. PubMed ID: 16046234
[TBL] [Abstract][Full Text] [Related]
33. Acquired Epidermodysplasia Verruciformis and Its Relationship to Immunosuppressive Therapy: Report of a Case and Review of the Literature.
Ovits CG; Amin BD; Halverstam C
J Drugs Dermatol; 2017 Jul; 16(7):701-704. PubMed ID: 28697224
[TBL] [Abstract][Full Text] [Related]
34. Karyotypic analysis of bone marrow cells in pyodermic lesions associated with myelodysplastic syndrome.
Hamada T; Matsuura H; Oono T; Morizane S; Yamasaki O; Asagoe K; Yamamoto T; Tsuji K; Iwatsuki K
Arch Dermatol; 2008 May; 144(5):643-8. PubMed ID: 18490591
[TBL] [Abstract][Full Text] [Related]
35. Epidemiologic aspects of epidermodysplasia verruciformis (L-L 1922) in Japan.
Tanigaki T; Kanda R; Yutsudo M; Hakura A
Jpn J Cancer Res; 1986 Sep; 77(9):896-900. PubMed ID: 3095286
[TBL] [Abstract][Full Text] [Related]
36. HPV5b variant in a neoplastic lesion of an Italian patient affected by epidermodysplasia verruciformis.
Muscardin LM; Poggiali F; Balus L; Venuti A
Eur J Dermatol; 2001; 11(6):572-5. PubMed ID: 11701412
[TBL] [Abstract][Full Text] [Related]
37. [Clinical analysis of 28 cases of pediatric myelodysplastic syndrome].
Xi WB; Wang D; Liu YF
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Jul; 15(7):514-8. PubMed ID: 23866269
[TBL] [Abstract][Full Text] [Related]
38. Association between epidermodysplasia verruciformis-associated human papillomavirus DNA in plucked eyebrow hair and solar keratoses.
Boxman IL; Russell A; Mulder LH; Bavinck JN; ter Schegget J; Green A;
J Invest Dermatol; 2001 Nov; 117(5):1108-12. PubMed ID: 11710920
[TBL] [Abstract][Full Text] [Related]
39. A novel human papillomavirus identified in epidermodysplasia verruciformis.
Harris AJ; Purdie K; Leigh IM; Proby C; Burge S
Br J Dermatol; 1997 Apr; 136(4):587-91. PubMed ID: 9155964
[TBL] [Abstract][Full Text] [Related]
40. Epidermodysplasia verruciformis and cutaneous human papillomavirus DNA, but not genital human papillomavirus DNAs, are frequently detected in vulvar and vaginal melanoma.
Rohwedder A; Slominski A; Wolff M; Kredentser D; Carlson JA
Am J Dermatopathol; 2007 Feb; 29(1):13-7. PubMed ID: 17284956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
